Copper Oxodotreotide CU-64
Overview
Copper Oxodotreotide CU-64 is a protein active pharmaceutical ingredient (ChEMBL CHEMBL4297339).
API suppliers (1)
Suppliers of Copper Oxodotreotide CU-64 evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
- CuriumUnited Kingdom1 active DMF
Patent & exclusivity (US)
Per the FDA Orange Book (1 approved US product), the latest listed US patent on Copper Oxodotreotide CU-64 expires 3 Sept 2041 and exclusivity 3 Sept 2027. Generic API sourcing typically opens up once these lapse.
Do you supply Copper Oxodotreotide CU-64? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.